These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36258171)

  • 41. Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study.
    Wurst KE; St Laurent S; Mullerova H; Davis KJ
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1021-31. PubMed ID: 25285002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study.
    Lee TM; Tu K; Wing LL; Gershon AS
    NPJ Prim Care Respir Med; 2017 May; 27(1):34. PubMed ID: 28507288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada.
    Tavakoli H; Johnson KM; FitzGerald JM; Sin DD; Gershon AS; Kendzerska T; Sadatsafavi M
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2003-2013. PubMed ID: 31564848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension.
    Lange TJ
    Herz; 2023 Aug; 48(4):259-265. PubMed ID: 37085727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β
    Requena G; Banks V; Czira A; Wood R; Tritton T; Wild R; Compton C; Duarte M; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1781-1795. PubMed ID: 35983168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
    Mueller S; Wilke T; Bechtel B; Punekar YS; Mitzner K; Virchow JC
    Respir Med; 2017 Jan; 122():1-11. PubMed ID: 27993284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Updated Perspectives on Pulmonary Hypertension in COPD.
    Blanco I; Tura-Ceide O; Peinado VI; Barberà JA
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1315-1324. PubMed ID: 32606641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension.
    Woods PR; Taylor BJ; Frantz RP; Johnson BD
    Am J Cardiol; 2012 Apr; 109(7):1066-72. PubMed ID: 22245407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions.
    Atchley WT; Kakkera TK
    Curr Opin Pulm Med; 2024 Mar; 30(2):150-155. PubMed ID: 38088383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis.
    Buhl R; Wilke T; Picker N; Schmidt O; Hechtner M; Kondla A; Maywald U; Vogelmeier CF
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2355-2367. PubMed ID: 36172035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.
    Keir GJ; Walsh SL; Gatzoulis MA; Marino PS; Dimopoulos K; Alonso R; Raposeiras-Roubin S; Renzoni EA; Maher TM; Wells AU; Wort SJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):82-90. PubMed ID: 25078636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dana Point: what is new in the treatment of pulmonary hypertension?].
    Hoeper MM; Ghofrani HA; Grimminger F; Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S191-5. PubMed ID: 18814094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.
    Launay D; Hachulla E; Hatron PY; Jais X; Simonneau G; Humbert M
    Medicine (Baltimore); 2007 Sep; 86(5):299-315. PubMed ID: 17873760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of adherence to inhaled medications among Veterans with COPD.
    Huetsch JC; Uman JE; Udris EM; Au DH
    J Gen Intern Med; 2012 Nov; 27(11):1506-12. PubMed ID: 22782274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.
    Holverda S; Bogaard HJ; Groepenhoff H; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Respiration; 2008; 76(2):160-7. PubMed ID: 17960052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England.
    Sansbury LB; Rothnie KJ; Bains C; Compton C; Anley G; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2591-2604. PubMed ID: 34552325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pulmonary hypertension in COPD and interstitial lung diseases].
    Markart P; Ghofrani HA; Grimminger F; Günther A
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.